Prostate-specific membrane antigen (PSMA)-PET/CT imaging identified metastatic prostate cancer in almost half of high-risk cases missed by conventional imaging, a retrospective analysis showed.

Patients with pulmonary sarcoidosis showed significantly higher uptake of the VAP-1–targeted PET tracer in the lungs and ...

New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society of Nuclear Medicine and Molecular Imaging, an international scientific and ...

The use of 18 F-fluoride positron emission tomography (PET)-computed tomography (CT) appears to be a more sensitive test than conventional assessments for the detection of subclinical valve ...

Rarely has a footnote garnered so much positive attention, but a reference in the newly updated prostate cancer guidelines from the National Comprehensive Cancer Network (NCCN) has prostate cancer ...

A proof-of-concept trial shows novel sarcoidosis PET/CT tracer detects inflammatory activity, supporting further clinical ...

The ability to follow patients with this high sensitivity allows us to make a more accurate and precise measurement, and we can see small changes or see them in a shorter period of time…,” ...

PET/CT images of mice that had ingested microplastics labelled with copper-64. The microplastics accumulated in the stomach (S) and intestine (I) for 24 h, and were observed in liver (L) 48 h after ...

Positron Corporation (OTC: POSC) (the “Company”), a leading molecular imaging medical device company specializing in Positron Emission Tomography (PET) and PET-CT imaging systems and clinical support ...